MeSH term
Frequency | Condition_Probility | Humans | 33 | 0.0 |
Adult | 14 | 0.0 |
Aged | 13 | 0.0 |
Female | 14 | 0.0 |
*Gene Expression | 5 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Male | 14 | 0.0 |
Middle Aged | 13 | 0.0 |
RNA, Messenger/analysis | 5 | 0.0 |
Receptors, Somatostatin/analysis/*genetics | 2 | 100.0 |
Research Support, Non-U.S. Gov't | 23 | 0.0 |
Animals | 14 | 0.0 |
Mice | 2 | 0.0 |
Immunohistochemistry | 6 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Aged, 80 and over | 5 | 0.0 |
Receptors, Somatostatin/*metabolism | 3 | 12.0 |
Adolescent | 4 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Receptors, Somatostatin/*genetics/*metabolism | 3 | 100.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Amino Acid Sequence | 8 | 0.0 |
Cell Division | 2 | 0.0 |
GTP-Binding Proteins/metabolism | 2 | 0.0 |
Molecular Sequence Data | 13 | 0.0 |
Signal Transduction | 4 | 0.0 |
Cell Line | 5 | 0.0 |
Substrate Specificity | 2 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Cyclic AMP/metabolism | 4 | 0.0 |
DNA, Complementary | 3 | 0.0 |
Forskolin/pharmacology | 2 | 0.0 |
Rats | 3 | 0.0 |
Transfection | 3 | 0.0 |
Polymerase Chain Reaction/methods | 3 | 0.0 |
Receptors, Somatostatin/*genetics | 4 | 14.0 |
Transcription, Genetic | 2 | 0.0 |
Up-Regulation | 2 | 0.0 |
DNA Primers | 4 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
RNA-Directed DNA Polymerase | 3 | 2.0 |
Gene Expression | 3 | 0.0 |
Base Sequence | 7 | 0.0 |
Comparative Study | 2 | 0.0 |
Receptors, Somatostatin/*biosynthesis | 2 | 28.0 |
RNA, Messenger/metabolism | 5 | 0.0 |
Receptors, Somatostatin/genetics/*metabolism | 2 | 15.0 |
Binding, Competitive | 2 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Octreotide/pharmacology | 2 | 8.0 |
CHO Cells | 2 | 0.0 |
Cricetulus | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Receptors, Somatostatin/drug effects/genetics/*metabolism | 2 | 40.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Blotting, Northern | 2 | 0.0 |
